Literature DB >> 10956261

Role of the renin-angiotensin system in regulation and autoregulation of renal blood flow.

C M Sorensen1, P P Leyssac, O Skott, N H Holstein-Rathlou.   

Abstract

The role for ANG II in renal blood flow (RBF) autoregulation is unsettled. The present study was designed to test the effect of clamping plasma ANG II concentrations ([ANG II]) by simultaneous infusion of the angiotensin-converting enzyme inhibitor captopril and ANG II on RBF autoregulation in halothane-anesthetized Sprague-Dawley rats. Autoregulation was defined as the RBF response to acute changes in renal perfusion pressure (RPP). Regulation was defined as changes in RBF during long-lasting changes in RPP. The results showed that a prolonged reduction of RPP reset the lower limit of autoregulation from 85 +/- 1 to 73 +/- 2 mmHg (P < 0.05) and regulated RBF to a lower level. Reduction of RPP to just above the lower limit of autoregulation (88 mmHg) induced regulation of RBF to a lower level within 10 min. Clamping [ANG II] per se reset the lower limit of autoregulation to 62 +/- 5 mmHg. In this case, reduction in RPP to 50 mmHg did not induce a downregulation of RBF. We conclude that ANG II plays an important role in the resetting of the autoregulation limits. The ability to regulate RBF to a new level as a response to changes in RPP also depends on changes in [ANG II].

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956261     DOI: 10.1152/ajpregu.2000.279.3.R1017

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  12 in total

1.  No apparent role for T-type Ca²⁺ channels in renal autoregulation.

Authors:  Rasmus Hassing Frandsen; Max Salomonsson; Pernille B L Hansen; Lars J Jensen; Thomas Hartig Braunstein; Niels-Henrik Holstein-Rathlou; Charlotte Mehlin Sorensen
Journal:  Pflugers Arch       Date:  2015-12-14       Impact factor: 3.657

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Clinical trials report. Chronic kidney disease: blood pressure, treatment goals, and cardiovascular outcomes.

Authors:  Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

Review 4.  Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure.

Authors:  Branko Braam; William A Cupples; Jaap A Joles; Carlo Gaillard
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

5.  Role of angiotensin II in dynamic renal blood flow autoregulation of the conscious dog.

Authors:  Armin Just; Heimo Ehmke; Uwe Wittmann; Hartmut R Kirchheim
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

6.  Renal Perfusion Pressure Determines Infiltration of Leukocytes in the Kidney of Rats With Angiotensin II-Induced Hypertension.

Authors:  Satoshi Shimada; Justine M Abais-Battad; Ammar J Alsheikh; Chun Yang; Megan Stumpf; Theresa Kurth; David L Mattson; Allen W Cowley
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

7.  Increased susceptibility to hypertensive renal disease in streptozotocin-treated diabetic rats is not modulated by salt intake.

Authors:  C A Sima; M P Koeners; J A Joles; B Braam; A B Magil; W A Cupples
Journal:  Diabetologia       Date:  2012-05-06       Impact factor: 10.122

Review 8.  Dietary salt, blood pressure, and microalbuminuria.

Authors:  Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-11       Impact factor: 3.738

9.  Thermal oscillations in rat kidneys: an infrared imaging study.

Authors:  Alexander M Gorbach; Hengliang Wang; Eric Elster
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2008-10-13       Impact factor: 4.226

Review 10.  Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor.

Authors:  Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-03       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.